Systematic review and meta-analysis to estimate the pooled prevalence of ADHD in adult attendees of outpatient mental health clinics and to investigate factors influencing prevalence rates.
Methods:
The following were extracted: demographics, design of the study (screening only or two-phase), scales/criteria for diagnosis of ADHD, number of ADHD, and non-ADHD participants.
Results:
The pooled prevalence of ADHD from screening studies (n = 9) was 26.7%, (95% CI [17.2–37.4]), ADHD = 1727, No ADHD = 3,578. From studies employing a two-stage design (n = 5), prevalence was 14.61%, CI [10.39–19.41], ADHD = 561, No ADHD = 3,578. Age and gender did not have any significant effect on the estimated prevalence. By contrast exclusion of psychotic disorders lowers prevalence. The screening scale used also influence prevalence rates.
Conclusion:
Meta-analysis shows high rates of adult ADHD among psychiatric outpatient clinics. Applying DSM-5 criteria increased prevalence rates. More methodologically robust studies, using two-stage design, need to be conducted to help assist in service planning.
Agnew-BlaisJ. C.PolanczykG. V.DaneseA.WertzJ.MoffittT. E.ArseneaultL. (2016). Evaluation of the persistence, remission, and emergence of attention-deficit/hyperactivity disorder in young adulthood. JAMA Psychiatry, 73(7), 713–720. https://doi.org/10.1001/jamapsychiatry.2016.0465
4.
Almeida MontesL. G.Hernández GarcíaA. O.Ricardo-GarcellJ. (2007). ADHD prevalence in adult outpatients with nonpsychotic psychiatric illnesses. Journal of Attention Disorders, 11(2), 150–156.
5.
American Psychiatric Association. (2013). Diagnostic and statistical manual of mental disorders (5th ed.) American Psychiatric Publishing Inc.
6.
Brainstorm Consortium, AnttilaV.Bulik-SullivanB.FinucaneH. K.WaltersR. K.MurrayR. (2018). Analysis of shared heritability in common disorders of the brain. Science, 360(6395). https://doi.org/10.1126/science.aap8757
7.
AshersonP.Agnew-BlaisJ. (2019). Annual research review: Does late-onset attention-deficit/hyperactivity disorder exist?Journal of Child Psychology and Psychiatry, 60(4), 333–352. https://doi.org/10.1111/jcpp.13020
8.
BalduzziS.RückerG.SchwarzerG. (2019). How to perform a meta-analysis with R: A practical tutorial. Evidence-Based Mental Health, 22(4), 153–160.
9.
BiedermanJ.DiSalvoM.WoodworthK. Y.FriedR.UchidaM.BiedermanI.SpencerT. J.SurmanC.FaraoneS. V. (2020). Toward operationalizing deficient emotional self-regulation in newly referred adults with ADHD: A receiver operator characteristic curve analysis. European Psychiatry, 63(1), e21. https://doi.org/10.1192/j.eurpsy.2019.11
10.
BiedermanJ.WilensT.MickE.FaraoneS. V.WeberW.CurtisS.ThornellA.PfisterK.JettonJ. G.SorianoJ. (1997). Is ADHD a risk factor for psychoactive substance use disorders? Findings from a four-year prospective follow-up study. Journal of the American Academy of Child and Adolescent Psychiatry, 36(1), 21–29. https://doi.org/10.1097/00004583-199701000-00013
11.
BitterI.MohrP.BaloghL.LátalováK.KakusziB.StopkováP.Zmeškalová-JelenováD.PulayA.CzoborP. (2019). ADHD: A hidden comorbidity in adult psychiatric patients. Attention Deficit and Hyperactivity Disorders, 11(1), 83–89. https://doi.org/10.1007/s12402-019-00285-9
12.
BuitelaarJ. K. (2002). Epidemiological aspects: What have we learned over the last decade? In SandbergS. (Ed.), Hyperactivity and attention disorders of childhood (2nd ed., pp. 30–64). Cambridge University Press.
13.
CayeA.RochaT. B.AnselmiL.MurrayJ.MenezesA. M.BarrosF. C.GonçalvesH.WehrmeisterF.JensenC. M.SteinhausenH. C.SwansonJ. M.KielingC.RohdeL. A. (2016). Attention-deficit/hyperactivity disorder trajectories from childhood to young adulthood: Evidence from a birth cohort supporting a late-onset syndrome. JAMA Psychiatry, 73(7), 705–712. https://doi.org/10.1001/jamapsychiatry.2016.0383
14.
CayeA.SibleyM. H.SwansonJ. M.RohdeL. A. (2017). Late-onset ADHD: Understanding the evidence and building theoretical frameworks. Current Psychiatry Reports, 19(12), 106. https://doi.org/10.1007/s11920-017-0858-7
15.
CayeA.SpadiniA. V.KaramR. G.GrevetE. H.RovarisD. L.BauC. H.RohdeL. A.KielingC. (2016). Predictors of persistence of ADHD into adulthood: A systematic review of the literature and meta-analysis. European Child & Adolescent Psychiatry, 25(11), 1151–1159. https://doi.org/10.1007/s00787-016-0831-8
16.
ChangZ.D’OnofrioB. M.QuinnP. D.LichtensteinP.LarssonH. (2016). Medication for attention-deficit/hyperactivity disorder and risk for depression: A nationwide longitudinal cohort study. Biological Psychiatry, 80(12), 916–922.
17.
DalsgaardS.MortensenP. B.FrydenbergM.MaibingC. M.NordentoftM.ThomsenP. H. (2014). Association between attention-deficit hyperactivity disorder in childhood and schizophrenia later in adulthood. European Psychiatry, 29(4), 259–263. https://doi.org/10.1016/j.eurpsy.2013.06.004
18.
DeberdtW.ThomeJ.LebrecJ.KraemerS.FregenalI.Ramos-QuirogaJ. A.ArifM. (2015). Prevalence of ADHD in nonpsychotic adult psychiatric care (ADPSYC): A multinational cross-sectional study in Europe. BMC Psychiatry, 15(1), 242. https://doi.org/10.1186/s12888-015-0624-5
19.
DemontisD.WaltersR. K.MartinJ.MattheisenM.AlsT. D.NealeB. M. (2019). Discovery of the first genome-wide significant risk loci for attention deficit/hyperactivity disorder. Nature Genetics, 51(1), 63–75. https://doi.org/10.1038/s41588-018-0269-7
20.
FaraoneS. V.BiedermanJ.MickE. (2006). The age-dependent decline of attention deficit hyperactivity disorder: A meta-analysis of follow-up studies. Psychological Medicine, 36(2), 159–165. https://doi.org/10.1017/S003329170500471X
21.
FayyadJ.SampsonN. A.HwangI.AdamowskiT.Aguilar-GaxiolaS.Al-HamzawiA.AndradeL. H.BorgesG.de GirolamoG.FlorescuS.GurejeO.HaroJ. M.HuC.KaramE. G.LeeS.Navarro-MateuF.O’NeillS.PennellB. E.PiazzaM.. . . KesslerR. C.; WHO World Mental Health Survey Collaborators. (2017). The descriptive epidemiology of DSM-IV adult ADHD in the World Health Organization World Mental Health surveys. Attention Deficit and Hyperactivity Disorders, 9(1), 47–65. https://doi.org/10.1007/s12402-016-0208-3
22.
GaubM.CarlsonC. L. (1997). Gender differences in ADHD: A meta-analysis and critical review. Journal of the American Academy of Child and Adolescent Psychiatry, 36(8), 1036–1045. https://doi.org/10.1097/00004583-199708000-00011
23.
GerhandS.SavilleC. W. N. (2021). ADHD prevalence in the psychiatric population. International Journal of Psychiatry in Clinical Practice. 1–13. https://doi.org/10.1080/13651501.2021.1914663
24.
GinsbergY.QuinteroJ.AnandE.CasillasM.UpadhyayaH. P. (2014). Underdiagnosis of attention-deficit/hyperactivity disorder in adult patients: A review of the literature. The Primary Care Companion For CNS Disorders, 16(3), https://doi.org/10.4088/PCC.13r01600
25.
GrevetE. H.BauC. H.SalgadoC. A.FischerA. G.KalilK.VictorM. M.GarciaC. R.SousaN. O.RohdeL. A.Belmonte-de-AbreuP. (2006). Lack of gender effects on subtype outcomes in adults with attention-deficit/hyperactivity disorder: Support for the validity of subtypes. European Archives of Psychiatry and Clinical Neuroscience, 256(5), 311–319. https://doi.org/10.1007/s00406-006-0639-5
26.
Guldberg-KjärT.JohanssonB. (2009). Old people reporting childhood AD/HD symptoms: Retrospectively self-rated AD/HD symptoms in a population-based Swedish sample aged 65–80. Nordic Journal of Psychiatry, 63(5), 375–382. https://doi.org/10.1080/08039480902818238
27.
Guldberg-KjarT.JohanssonB. (2015). ADHD symptoms across the lifespan: A comparison of symptoms captured by the Wender and Barkley Scales and DSM-IV criteria in a population-based Swedish sample aged 65 to 80. Journal of Attention Disorders, 19(5), 390–404. https://doi.org/10.1177/1087054713514853
28.
HennigT.JayaE. S.KoglinU.LincolnT. M. (2017). Associations of attention-deficit/hyperactivity and other childhood disorders with psychotic experiences and disorders in adolescence. European Child & Adolescent Psychiatry, 26(4), 421–431. https://doi.org/10.1007/s00787-016-0904-8
29.
HigginsJ.ThompsonS.DeeksJ.AltmanD. (2002). Statistical heterogeneity in systematic reviews of clinical trials: A critical appraisal of guidelines and practice. Journal of Health Services Research & Policy, 7(1), 51–61. https://doi.org/10.1258/1355819021927674
30.
HozoS. P.DjulbegovicB.HozoI. (2005). Estimating the mean and variance from the median, range, and the size of a sample. BMC Medical Research Methodology, 5, 13. https://doi.org/10.1186/1471-2288-5-13
31.
JutlaA.CalifanoA.DishyG.HessonH.KennedyL.LundgrenB.PiaT.Veenstra-VanderWeeleJ.BrucatoG.GirgisR. R. (2020). Neurodevelopmental predictors of conversion to schizophrenia and other psychotic disorders in adolescence and young adulthood in clinical high risk individuals. Schizophrenia Research, 224, 170–172. https://doi.org/10.1016/j.schres.2020.10.008
32.
KatzmanM. A.BilkeyT. S.ChokkaP. R.FalluA.KlassenL. J. (2017). Adult ADHD and comorbid disorders: Clinical implications of a dimensional approach. BMC Psychiatry, 17(1), 302. https://doi.org/10.1186/s12888-017-1463-3
33.
KesslerR. C.AdlerL.AmesM.BarkleyR. A.BirnbaumH.GreenbergP.JohnstonJ. A.SpencerT.??st??nT. B. (2005). The prevalence and effects of adult attention deficit/hyperactivity disorder on work performance in a nationally representative sample of workers. Journal of Occupational and Environmental Medicine, 47(6), 565–572. https://doi.org/10.1097/01.jom.0000166863.33541.39
34.
KooijJ. J.BuitelaarJ. K.van Den OordE. J.FurerJ. W.RijndersC. A.HodiamontP. P. (2005). Internal and external validity of attention-deficit hyperactivity disorder in a population-based sample of adults. Psychological Medicine, 35(6), 817–827. https://doi.org/10.1017/s003329170400337x
35.
KooijS. J.BejerotS.BlackwellA.CaciH.Casas-BruguéM.CarpentierP. J.EdvinssonD.FayyadJ.FoekenK.FitzgeraldM.GaillacV.GinsbergY.HenryC.KrauseJ.LensingM. B.ManorI.NiederhoferH.Nunes-FilipeC.OhlmeierM. D.. . . AshersonP. (2010). European consensus statement on diagnosis and treatment of adult ADHD: The European Network Adult ADHD. BMC Psychiatry, 10, 67. https://doi.org/10.1186/1471-244X-10-67
36.
LeungV. M.ChanL. F. (2017). A cross-sectional cohort study of prevalence, co-morbidities, and correlates of attention-deficit hyperactivity disorder among adult patients admitted to the Li Ka Shing psychiatric outpatient clinic, Hong Kong. East Asian Arch Psychiatry, 27(2), 63–70.
37.
MaoA. R.FindlingR. L. (2014). Comorbidities in adult attention-deficit/hyperactivity disorder: A practical guide to diagnosis in primary care. Postgraduate Medicine, 126(5), 42–51. https://doi.org/10.3810/pgm.2014.09.2799
38.
McCarthyS.WiltonL.MurrayM.HodgkinsP.AshersonP.WongI. C. (2013). Management of adult attention deficit hyperactivity disorder in UK primary care: A survey of general practitioners. Health and Quality of Life Outcomes, 11, 22. https://doi.org/10.1186/1477-7525-11-22
39.
MichielsenM.SemeijnE.ComijsH. C.van de VenP.BeekmanA. T.DeegD. J.KooijJ. J. (2012). Prevalence of attention-deficit hyperactivity disorder in older adults in The Netherlands. The British Journal of Psychiatry, 201(4), 298–305. https://doi.org/10.1192/bjp.bp.111.101196
40.
MoffittT. E.HoutsR.AshersonP.BelskyD. W.CorcoranD. L.HammerleM.HarringtonH.HoganS.MeierM. H.PolanczykG. V.PoultonR.RamrakhaS.SugdenK.WilliamsB.RohdeL. A.CaspiA. (2015). Is adult ADHD a childhood-onset neurodevelopmental disorder? Evidence from a four-decade longitudinal cohort study. American Journal of Psychiatry, 172(10), 967–977. https://doi.org/10.1176/appi.ajp.2015.14101266
41.
MoherD.LiberatiA.TetzlaffJ.AltmanD. G.; PRISMA Group. (2009). Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement. PLoS Medicine, 6(7), e1000097. https://doi.org/10.1371/journal.pmed.1000097
42.
MunnZ.MoolaS.RiitanoD.LisyK. (2014). The development of a critical appraisal tool for use in systematic reviews addressing questions of prevalence. International Journal of Health Policy and Management, 3(3), 123–128. https://doi.org/10.15171/ijhpm.2014.71
43.
NylanderL.HolmqvistM.GustafsonL.GillbergC. (2009). ADHD in adult psychiatry. Minimum rates and clinical presentation in general psychiatry outpatients. Nordic Journal of Psychiatry, 63(1), 64–71. https://doi.org/10.1080/08039480802416323
44.
Olde LoohuisL. M.MennigenE.OriA. P.PerkinsD.RobinsonE.AddingtonJ.CadenheadK. S.CornblattB. A.MathalonD. H.McGlashanT. H.SeidmanL. J.KeshavanM. S.StoneW. S.TsuangM. T.WalkerE. F.WoodsS. W.CannonT. D.GurR. C.GurR. E.. . . OphoffR. A. (2021). Genetic and clinical analyses of psychosis spectrum symptoms in a large multiethnic youth cohort reveal significant link with ADHD. Translational Psychiatry, 11(1), 80. https://doi.org/10.1038/s41398-021-01203-2
45.
PolanczykG.JensenP. (2008). Epidemiologic considerations in attention deficit hyperactivity disorder: A review and update. Child and Adolescent Psychiatric Clinics of North America, 17(2), 245–260, vii. https://doi.org/10.1016/j.chc.2007.11.006
46.
RaoP.PlaceM. (2011). Prevalence of ADHD in four general adult outpatient clinics in North East England. Progress in Neurology and Psychiatry, 15(5), 7–10. https://doi.org/10.1002/pnp.211
RucklidgeJ. J. (2010). Gender differences in attention-deficit/hyperactivity disorder. Psychiatric Clinics of North America, 33(2), 357–373. https://doi.org/10.1016/j.psc.2010.01.006
49.
SibleyM. H.RohdeL. A.SwansonJ. M.HechtmanL. T.MolinaB. S. G.MitchellJ. T.ArnoldL. E.CayeA.KennedyT. M.RoyA.StehliA.; Multimodal Treatment Study of Children with ADHD (MTA) Cooperative Group. (2018). Late-onset ADHD reconsidered with comprehensive repeated assessments between ages 10 and 25. American Journal of Psychiatry, 175(2), 140–149. https://doi.org/10.1176/appi.ajp.2017.17030298
50.
SimonV.CzoborP.BálintS.MészárosA.BitterI. (2009). Prevalence and correlates of adult attention-deficit hyperactivity disorder: Meta-analysis. The British Journal of Psychiatry, 194(3), 204–211. https://doi.org/10.1192/bjp.bp.107.048827
51.
SternatT.FotinosK.FineA.EpsteinI.KatzmanM. (2018). Low hedonic tone and attention-deficit hyperactivity disorder: Risk factors for treatment resistance in depressed adults. Neuropsychiatric Disease and Treatment, 14, 2379–2387.
52.
StickleyA.TachimoriH.InoueY.ShinkaiT.YoshimuraR.NakamuraJ.MoritaG.NishiiS.TokutsuY.OtsukaY.EgashiraK.InoueM.KuboT.TesenH.TakashimaN.TominagaH.KoyanagiA.KamioY. (2018). Attention-deficit/hyperactivity disorder symptoms and suicidal behavior in adult psychiatric outpatients. Psychiatry and Clinical Neurosciences, 72(9), 713–722. https://doi.org/10.1111/pcn.12685
53.
SyedH.MasaudT. M.NkireN.IroC.GarlandM. R. (2010). Estimating the prevalence of adult ADHD in the psychiatric clinic: a cross-sectional study using the adult ADHD self-report scale (ASRS). Irish Journal of Psychological Medicine, 27(4), 195-197. https://doi.org/10.1017/S079096670000152X.
54.
TaylorL. E.Kaplan-KahnE. A.LighthallR. A.AntshelK. M. (2021). Adult-onset ADHD: A critical analysis and alternative explanations. Child Psychiatry and Human Development. https://doi.org/10.1007/s10578-021-01159-w
55.
TurgayA.GoodmanD. W.AshersonP.LasserR. A.BabcockT. F.PucciM. L.BarkleyR.; ADHD Transition Phase Model Working Group. (2012). Lifespan persistence of ADHD: The life transition model and its application. Journal of Clinical Psychiatry, 73(2), 192–201. https://doi.org/10.4088/JCP.10m06628
56.
ValsecchiP.NibbioG.RosaJ.TamussiE.TurrinaC.SacchettiE.VitaA. (2021). Adult ADHD: Prevalence and clinical correlates in a sample of Italian psychiatric outpatients. Journal of Attention Disorders, 25(4), 530–539. https://doi.org/10.1177/1087054718819824
57.
van de GlindG.KonsteniusM.KoeterM. W. J.van Emmerik-van OortmerssenK.CarpentierP. J.KayeS.DegenhardtL.SkutleA.FranckJ.BuE. T.MoggiF.DomG.VerspreetS.DemetrovicsZ.Kapitány-FövényM.FatséasM.AuriacombeM.SchillingerA.MøllerM.. . . van Den BrinkW.; IASP Research Group. (2014). Variability in the prevalence of adult ADHD in treatment seeking substance use disorder patients: Results from an international multi-center study exploring DSM-IV and DSM-5 criteria. Drug and Alcohol Dependence, 134, 158–166. https://doi.org/10.1016/j.drugalcdep.2013.09.026
58.
van Emmerik-van OortmerssenK.van de GlindG.van Den BrinkW.SmitF.CrunelleC. L.SwetsM.SchoeversR. A. (2012). Prevalence of attention-deficit hyperactivity disorder in substance use disorder patients: A meta-analysis and meta-regression analysis. Drug and Alcohol Dependence, 122(1–2), 11–19. https://doi.org/10.1016/j.drugalcdep.2011.12.007
59.
ViechtbauerW. (2010). Conducting meta-analyses in R with the metafor Package. Journal of Statistical Software, 36(3), 1–48.
60.
WanX.WangW.LiuJ.TongT. (2014). Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile range. BMC Medical Research Methodology, 14, 135. https://doi.org/10.1186/1471-2288-14-135
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
